March 20, 20231:13 AM CDT
Last Updated 11 hours ago
By Jennifer Rigby
LONDON, March 20 (Reuters) - Some of the world's leading makers of flu vaccines say they could make hundreds of millions of bird flu shots for humans within months if a new strain of avian influenza ever jumps across the species divide.
... Executives at three vaccine manufacturers – GSK Plc (GSK.L)Moderna Inc (MRNA.O) and CSL Seqirus, owned by CSL Ltd (CSL.AX)- told Reuters they are already developing or about to test sample human vaccines that better match the circulating subtype, as a precautionary measure against a future pandemic.
Others, like Sanofi (SASY.PA), said they "stand ready" to begin production if needed, with existing H5N1 vaccine strains in stock.
There has also been a push among companies to develop a bird flu vaccine for poultry, a market potentially far larger than that for humans. ...
Last Updated 11 hours ago
By Jennifer Rigby
LONDON, March 20 (Reuters) - Some of the world's leading makers of flu vaccines say they could make hundreds of millions of bird flu shots for humans within months if a new strain of avian influenza ever jumps across the species divide.
... Executives at three vaccine manufacturers – GSK Plc (GSK.L)Moderna Inc (MRNA.O) and CSL Seqirus, owned by CSL Ltd (CSL.AX)- told Reuters they are already developing or about to test sample human vaccines that better match the circulating subtype, as a precautionary measure against a future pandemic.
Others, like Sanofi (SASY.PA), said they "stand ready" to begin production if needed, with existing H5N1 vaccine strains in stock.
There has also been a push among companies to develop a bird flu vaccine for poultry, a market potentially far larger than that for humans. ...